Moorfields Eye Hospital, UCL Institute of Ophthalmology (IoO) and Topcon Healthcare launched a London-based medical technology company on May 9 called Cascader, which aimed to transform the detection and management of eye disease through artificial intelligence (AI).
Through combining the AI research and translational expertise of Moorfields and UCL IoO with the technical capabilities and international reach of Topcon Healthcare, Cascader aimed to accelerate the development of real-world clinical tools to benefit more patients, faster.
The company also sought to build on the field of oculomics, using retinal imaging to uncover insights into systemic conditions, such as cardiovascular disease, neurodegeneration and dementia.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here
